SUNSCREEN CREAM SPF 30- homosalate, octyl methoxycinnamate, benzophenone-3, titanium dioxide cream 
Davemed Healthcare Co., Ltd

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Sunscreen Cream SPF 30

Active Ingredients

Active ingredients Purpose

Homosalate..................................Sunscreen

Octyl methoxycinnamate..............Sunscreen

Benzophenone-3..........................Sunscreen

Titanium dioxide...........................Sunscreen

Purpose

Active ingredients Purpose

Homosalate..................................Sunscreen

Octyl methoxycinnamate..............Sunscreen

Benzophenone-3..........................Sunscreen

Titanium dioxide...........................Sunscreen

Uses

Uses

For external use only

When using this product

Stop use and ask a doctor if rash or irritation develops and lasts

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children

Directions

Inactive ingredients

Water, Cetearyl Alcohol, Glycerin monosteareate Gctt, Propylparaben, Methylparaben, glycerol, EDTA-2NA, Vinylchloride-methylacrylate, copolymer, Methylisothiazolinone

Other Information

Other Information

Store at room temperature

Principal Display Panel

label

SUNSCREEN CREAM SPF 30 
homosalate, octyl methoxycinnamate, benzophenone-3, titanium dioxide cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70897-008
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE4 g  in 100 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE4 g  in 100 mL
OXYBENZONE (UNII: 95OOS7VE0Y) (OXYBENZONE - UNII:95OOS7VE0Y) OXYBENZONE3 g  in 100 mL
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE7 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
GLYCERIN (UNII: PDC6A3C0OX)  
EDETIC ACID (UNII: 9G34HU7RV0)  
VINYL CHLORIDE (UNII: WD06X94M2D)  
GLATIRAMER ACETATE (UNII: 5M691HL4BO)  
DIGLYCERIN MONOSTEARATE (UNII: E3XK1VOF1Y)  
WATER (UNII: 059QF0KO0R)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
METHYLISOTHIAZOLINONE (UNII: 229D0E1QFA)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70897-008-016 mL in 1 BOTTLE; Type 0: Not a Combination Product02/01/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35202/01/2019
Labeler - Davemed Healthcare Co., Ltd (529128716)
Establishment
NameAddressID/FEIBusiness Operations
Davemed Healthcare Co., Ltd529128716manufacture(70897-008)

Revised: 1/2019
Document Id: 803be17d-c513-0db7-e053-2a91aa0a07f6
Set id: 803bf1cc-331b-2ce7-e053-2a91aa0a1d53
Version: 1
Effective Time: 20190124
 
Davemed Healthcare Co., Ltd